Enter your login e-mail to the account
Search
Search parameters
Search results
- The role of fibrates in a statin world
MUDr. Ľubomíra Fábryová, PhD.
(11/2009, Topic of the year ) - Svetový deň diabetu: vážne upozornenia
Magdaléna Žiaková
(11/2009, Information & comments ) - Evolokumab pro léčbu familiární hypercholesterolémie
prof. MUDr. Vladimír Bláha, CSc.
(4/2018, Drugs & drug classes ) - GLITAZONES – PAST, PRESENT AND FUTURE
PharmDr. Tomáš Tesař, PhD., MBA, MUDr. Adriana Ilavská
(9/2008, clearly ) - Combined hypolipidemic therapy in current clinical practice
MUDr. Ľubomíra Fábryová, PhD.
(6/2014, Review articles ) - Adherence and how to influence it
doc. MUDr. Michal Vrablík, Ph.D.
(2/2014, Review articles ) - Reach target LDL cholesterol more effective dose of atorvastatin 30 mg in the practice of general practitioners
MUDr. Martin Čaprnda, PhD., MUDr. Ján Hencel, MSc., Mgr. Ján Farkašovský, PharmDr. Silvia Encingerová, Mgr. Oliver Tlčimuka
(5/2015, Original articles & case reports ) - DIABETIC DYSLIPIDAEMIA – IMPORTANT PART OF THE COMPLEX CARE FOR THE PATIENTS WITH DIABETES TYPE 2
MUDr. Ľubomíra Fábryová
(1/2005, Topic ) - Adiposopathic dyslipidaemia
MUDr. Ľubomíra Fábryová, PhD., MPH
(6/2021, Topic of the year ) - MANAGEMENT OF ATHEROGENIC DYSLIPIDAEMIA IN THE METABOLIC SYNDROME
MUDr. Ľubomíra Fábryová
(S4/2007, Supplement ) - METABOLIC SYNDROME, CARDIOVASCULAR AND METABOLIC RISK
prof. MUDr. Peter Galajda, CSc.
(S4/2007, Supplement ) - Simultaneous intervention for arterial hypertension and dyslipidaemia
MUDr. Eva Tůmová, Ph.D.
(3/2021, Review articles ) - MANAGING DYSLIPIDAEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE
MUDr. Ľubomíra Fábryová
(10/2005, Topic ) - Role of niacin in a hypolipidaemic treatment in high cardiovascular risk patients
prof. MUDr. Andrej Dukát, CSc., doc. MUDr. Ľudovít Gašpar, CSc., MUDr. Peter Minárik, doc. MUDr. Martin Wawruch, PhD., doc. MUDr. Stanislav Oravec, CSc., MUDr. Peter Sabaka
(1/2010, Topic of the year ) - INSULIN RESISTANCE AND THE POLYCYSTIC OVARY SYNDROME
prof. MUDr. Ivica Lazúrová, CSc., MUDr. Ingrid Dravecká
(5/2005, Topic ) - WEIGHT MANAGEMENT FOR OBESE TYPE 2 DIABETICS
MUDr. Ľubomíra Fábryová, PhD.
(7-8/2008, Topic ) - RELATIONSHIP OF VISCERAL OBESITY TO CARDIOMETABOLIC RISK FACTORS
MUDr. Ľubomíra Fábryová, PhD.
(3/2008, Topic )
- Treatment with atypical antipsychotic drugs and their selection based on the spectrum of side effects
doc. MUDr. Radovan Přikryl, Ph.D.
(1/2009, Review articles ) - Metabolic syndrome in the context of psychiatric disorders and psychotropic treatment
MUDr. Jozef Dragašek, PhD.
(1/2014, Review articles ) - Prevention of cardiovascular risk and diabetes in schizophrenia patients: application of internet in clinical praxis
MUDr. Jiří Masopust, Ph.D., MUDr. Radovan Malý, Ph.D.
(5–6/2010, In short )
- Statin myopathy
Prof. MUDr. Josef Bednařík, CSc., MUDr. Eva Vlčková, Ph.D., MUDr. Tomáš Horák
(1/2017, Main topic )
- Recommendations for diagnosis and treatment of dyslipidaemia in children and adolescents
MUDr. Ľubomíra Fábryová, PhD., MUDr. Anna Hlavatá, PhD.
(S1/2011, Review articles )
- Metabolism and sex, sex and metabolism
MUDr. Michaela Šnejdrlová, Ph.D.
(1/2017, SEXUAL AND REPRODUCTIVE MEDICINE FOR PRACTICE )
- Impact of life style change to biochemical parameters in psoriasis patients
MUDr. Zuzana Rajczyová, Ing. Pavel Blažíček, CSc., prof. MUDr. Mária Šimaljaková, PhD., MHA
(1/2016, Original articles & case reports )
- Pharmacist´s role in educating a patient with diabetes mellitus – part II.
PharmDr. Lucia Masaryková, PhD., Doc. RNDr. Magdaléna Fulmeková, CSc., PharmDr. Ľubica Lehocká, PhD.
(2/2017, Clinical pharmacy ) - What can statins do in the management of cardiovascular deseases?
MUDr. Marta Filková, prof. MUDr. Ján Murín, CSc.,, MUDr. Miroslav Pernický
(1/2013, Current pharmacotherapy ) - Pharmacist´s role in educating a patient with diabetes mellitus – part I
PharmDr. Lucia Masaryková, PhD.,, Doc. RNDr. Magdaléna Fulmeková, CSc., PharmDr. Ľubica Lehocká, PhD.
(1/2017, Clinical pharmacy )
- Higher preprocedural fibrinogen levels are associated with sac regression after endovacular abdominal aneurysm repair
MUDr. Mária Rašiová, PhD., MUDr. Martin Koščo, RNDr. Viera Habalová, PhD., MUDr. Zuzana Tormová, MUDr. Martin Bujdoš, MUDr. Matej Moščovič, prof. MUDr. Ivan Tkáč, PhD.
(1/2019, Original articles ) - The impact of type II endoleak on aneurysm sac dynamics after endovascular abdominal aortic aneurysm repair
MUDr. Mária Rašiová, PhD., MUDr. Martin Koščo, MUDr. Ľubomír Špak, MPH, RNDr. Viera Habalová, PhD., MUDr. Ľudmila Farkašová, PhD., MUDr. Matej Moščovič, MUDr. Marek Hudák, PhD.
(2-3/2018, Original articles & Case reports ) - Significance of hematological markers on cardiovascular risk
MUDr. Marek Kučera, PhD., MHA, MPH
(2/2019, Original articles & Case reports ) - The factors associated with persistent type II endoleak after endovascular abdominal aortic aneurysm repair
MUDr. Martin Koščo, MUDr. Matej Moščovič, MUDr. Viera Habalová, MUDr. Jozef Židzik, MUDr. Zuzana Tormová, MUDr. Viktor Kožár, MUDr. Veronika Pavlíková, Doc. MUDr. Mária Rašiová, PhD.
(2/2022, Original articles )
- Perioperative complications in thoracic surgery patients with metabolic syndrome
doc. MUDr. Ľudovít Gašpar, CSc., MUDr. Michal Makovník, MUDr. Peter Poliak, PhD., MUDr. Juraj Koutun, CSc., MUDr. Stella Hlinšťáková
(4/2012, Original articles )